Bleeding Disorders Awareness Month: Elevating Education, Advocacy & Access

Every March, Bleeding Disorders Awareness Month shines a spotlight on individuals and families living with inherited and acquired bleeding disorders. It’s a time to raise awareness, promote early diagnosis, advocate for access to care, and celebrate the strength of a deeply resilient community.

For those working across specialty pharmacy, infusion, rare disease, and market access, this month serves as an important reminder: access to therapy isn’t just clinical, it’s life-changing.

Understanding Bleeding Disorders

Bleeding disorders occur when the blood does not clot properly due to missing or deficient clotting factors. The most well-known include:

• Hemophilia A
• Hemophilia B
• von Willebrand disease

These conditions can lead to prolonged bleeding after injury or surgery, spontaneous internal bleeding, joint damage, and other serious complications if not properly managed.

Today, advances in factor replacement therapies, non-factor therapies, and gene therapy research are transforming what is possible, shifting the conversation from survival to quality of life.

The Importance of Specialized Care

Patients with bleeding disorders often rely on:

• Comprehensive care through Hemophilia Treatment Centers (HTCs)
• Specialty pharmacy coordination
• Home infusion services
• Strong payer navigation and prior authorization expertise
• Ongoing patient education and adherence support

Treatment plans are highly individualized. Consistency, access, and clinical coordination make the difference between stability and preventable complications.

For many families, therapy is routine. Weekly or even multiple infusions per week can be required. That means supply chain reliability, benefits verification accuracy, and strong provider relationships are essential.

Advocacy & Community Impact

Organizations like National Bleeding Disorders Foundation (formerly NHF) and the World Federation of Hemophilia continue to lead education, research funding, and policy advocacy efforts.

Their work focuses on:

• Expanding access to comprehensive care
• Advancing research toward curative therapies
• Supporting equitable treatment globally
• Empowering patients and caregivers through education

Awareness months matter because they create space for conversations within healthcare, communities, schools, and workplaces.

Where the Industry Plays a Role

For professionals across:

• Specialty pharmacy
• Rare disease biotech
• Market access & trade
• Infusion services
• Commercial & territory leadership

Bleeding Disorders Awareness Month is a reminder of the human impact behind every therapy, prior authorization, and territory plan.

Innovation is moving quickly. However, without access, even the most advanced therapies cannot make a meaningful impact.

It takes collaboration between manufacturers, payers, specialty pharmacies, treatment centers, advocacy organizations, and commercial teams to ensure patients receive therapies without unnecessary barriers.

Moving Forward

Awareness is only the first step.

Education leads to earlier diagnosis. Access leads to better outcomes. Advocacy leads to systemic change.

This month, we honor the patients living courageously, the caregivers advocating fiercely, and the healthcare teams committed to improving outcomes in bleeding disorders.

Every advancement, relationship and access point matters in patient care.